GPCs AS MODIFIERS OF THE IRRTK AND p21 PATHWAYS AND METHODS OF USE
摘要
Human GPC genes are identified as modulators of the IRRTK of p21 pathways, and thus are therapeutic targets for disorders associated with defective IRRTK or p21 function. Methods for identifying modulators of IRRTK or p21, comprising screening for agents that modulate the activity of GPC are provided.
申请公布号
WO03006611(A3)
申请公布日期
2003.11.27
申请号
WO2002US21694
申请日期
2002.07.10
申请人
EXELIXIS, INC.;FRIEDMAN, LORI;PLOWMAN, GREGORY, D.;KADYK, LISA, C.;LI, DANXI;FUNKE, ROEL, P.
发明人
FRIEDMAN, LORI;PLOWMAN, GREGORY, D.;KADYK, LISA, C.;LI, DANXI;FUNKE, ROEL, P.
